InsiderCluster

DFTX

NasdaqGS

Definium Therapeutics, Inc.

$42.80
-1.49 (-3.36%)

Price

-4.38% over 1D

Key statistics

Previous close$44.29
Day range42.75 – 45.31
52-week range7.96 – 49.20
Volume1.22M
CurrencyUSD
ExchangeNasdaqGS
Crowd sentiment
86Bullish

Insider activity

SEC EDGAR ↗
Open-mkt buys
0
$0.00
Open-mkt sells
5
$2,617,638.93
Net flow
2.62M
5 open-market trades

Showing 10 recent filings. 5 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.

InsiderTypeSharesPriceValueDate
Sullivan Mark
Chief Legal Officer
Sell (open market)13.01K$45.03$585,750.242026-06-25
Roberts Brandi
Chief Financial Officer
Sell (open market)3.01K$45.03$135,675.392026-06-25
Barrow Robert
Director, Chief Executive Officer
Sell (open market)29.21K$45.03$1,315,236.242026-06-25
Karlin Daniel
Chief Medical Officer
Sell (open market)10.04K$45.03$451,876.052026-06-25
Wiley Matthew T.
Chief Commercial Officer
Sell (open market)2.87K$45.03$129,101.012026-06-25
Wiley Matthew T.
Chief Commercial Officer
Grant / award62.5K$0.002026-06-22
Barrow Robert
Director, Chief Executive Officer
Grant / award375K$0.002026-06-22
Roberts Brandi
Chief Financial Officer
Grant / award62.5K$0.002026-06-22
Sullivan Mark
Chief Legal Officer
Grant / award62.5K$0.002026-06-22
Karlin Daniel
Chief Medical Officer
Grant / award100K$0.002026-06-22

Source: SEC EDGAR Forms 4/4A (CIK 1813814). Click an insider to open the original filing.

Social sentiment

86
Bullish

Volume-weighted across live social sources

StockTwitsLIVE
6 bull861 bear
Recent posts
@Nonstopmunchies· StockTwits1d ago

@Millionaire11 it isn't even the main selling point for $DFTX, just a bonus ;) All i'm hearing from CMPS folks can be summarized like this "waaa waaa, my younger brother excels at Football and Basketball, but I'm only good at Basketball, why did he get a scholarship for Basketball?!? life isn't fair😭" quit whining and complaining, your time will come, just be patient.

@twiggs462· StockTwits1d ago

@Millionaire11 Lycos was denied FDA approval due to non-ethical trial designs. $DFTX will be fine.

@twiggs462· StockTwits2d ago

@Millionaire11 mushrooms work and $CMPS will still be a great play, but LSD will be shown to shake its stigma. $DFTX just will have the suspense headlines. It will bode well for both in the very near term.

@Millionaire11· StockTwits2d ago

@twiggs462 it will be $CMPS first mover advantage. News headlines will not be $DFTX

@Millionaire11· StockTwits2d ago

$CMPS $DFTX

@TurboFrogz· StockTwits2d ago

@leLu83 average retail price is roughly 6.90 for ATAI, very small gains. YTD gains would be roughly 70%. Still good. $DFTX average retail price is 37.80. Already great gains. YTD is 230%. You might be able to fool 3rd graders with your comments but unfortunately for you most users here are grown adults that can do math. Not to mention ATAI gains are maxed out and capped. DFTX is just beginning!

@VikaDelic· StockTwits2d ago

$DFTX tell me you already spent that tiny ATAI payout, without telling me 🤣 get ready to see how it’s done my sad bro…

@twiggs462· StockTwits2d ago

I personally think $ATAI sold becuase they know that cannot compete with $DFTX or $CMPS short term. Those two are going to take the spotlight and investors and $ATAI would have run out of money. I bet $LLY will take BPL-003 to market, but $ATAI would have not been able to

@twiggs462· StockTwits2d ago

$DFTX will be the darling in the space. it will soon be front page news.

@leLu83· StockTwits3d ago

$DFTX investors from 2021 still in the Red 😂

@UncleJudd· StockTwits3d ago

$DFTX $CMPS Worth reading. https://www.psychologytoday.com/ca/blog/addiction-outlook/202607/how-can-a-drug-lasting-hours-change-the-brain-for-months

@WhizBuckley· StockTwits3d ago

$ATAI word salad for "I needed the money" https://christianangermayer.substack.com/p/my-love-letter-to-psychedelics-and $DFTX $CMPS $HELP $GHRS

Latest news

Get insider-buy alerts

Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.